BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choudhary A, Zachek B, Lera RF, Zasadil LM, Lasek A, Denu RA, Kim H, Kanugh C, Laffin JJ, Harter JM, Wisinski KB, Saha S, Weaver BA, Burkard ME. Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer. Mol Cancer Ther 2016;15:48-59. [PMID: 26586723 DOI: 10.1158/1535-7163.MCT-15-0527] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tran TTD, Tran PHL. Lead Compounds in the Context of Extracellular Vesicle Research. Pharmaceutics 2020;12:E716. [PMID: 32751565 DOI: 10.3390/pharmaceutics12080716] [Reference Citation Analysis]
2 Denu RA, Burkard ME. Analysis of the "centrosome-ome" identifies MCPH1 deletion as a cause of centrosome amplification in human cancer. Sci Rep 2020;10:11921. [PMID: 32681070 DOI: 10.1038/s41598-020-68629-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Newcomb R, Dean E, McKinney BJ, Alvarez JV. Context-dependent effects of whole-genome duplication during mammary tumor recurrence. Sci Rep 2021;11:14932. [PMID: 34294755 DOI: 10.1038/s41598-021-94332-z] [Reference Citation Analysis]
4 Gao C, Li H, Zhou C, Liu C, Zhuang J, Liu L, Sun C. Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer. Front Endocrinol 2022;13:813306. [DOI: 10.3389/fendo.2022.813306] [Reference Citation Analysis]
5 Denu RA, Zasadil LM, Kanugh C, Laffin J, Weaver BA, Burkard ME. Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer. BMC Cancer 2016;16:47. [PMID: 26832928 DOI: 10.1186/s12885-016-2083-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 7.8] [Reference Citation Analysis]
6 To SKY, Tang MKS, Tong Y, Zhang J, Chan KKL, Ip PPC, Shi J, Wong AST. A Selective β-Catenin-Metadherin/CEACAM1-CCL3 Axis Mediates Metastatic Heterogeneity upon Tumor-Macrophage Interaction. Adv Sci (Weinh) 2022;:e2103230. [PMID: 35403834 DOI: 10.1002/advs.202103230] [Reference Citation Analysis]
7 Denu RA, Kaur G, Sass MM, Lakkaraju A, Burkard ME. Centrosome Amplification in Cancer Disrupts Autophagy and Sensitizes to Autophagy Inhibition. Mol Cancer Res 2020;18:33-45. [PMID: 31604847 DOI: 10.1158/1541-7786.MCR-19-0509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Matson DR, Denu RA, Zasadil LM, Burkard ME, Weaver BA, Flynn C, Stukenberg PT. High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability. BMC Cancer 2021;21:186. [PMID: 33622270 DOI: 10.1186/s12885-021-07893-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang L, Ouyang M, Xing S, Zhao S, Liu S, Sun L, Yu H, Pragasam V. Mesenchymal Stem Cells and their Derived Exosomes Promote Malignant Phenotype of Polyploid Non-Small-Cell Lung Cancer Cells through AMPK Signaling Pathway. Analytical Cellular Pathology 2022;2022:1-15. [DOI: 10.1155/2022/8708202] [Reference Citation Analysis]
10 Giuglio-Tonolo AG, Curti C, Terme T, Vanelle P. A Survey of Synthetic Routes and Antitumor Activities for Benzo[g]quinoxaline-5,10-diones. Molecules 2020;25:E5922. [PMID: 33327601 DOI: 10.3390/molecules25245922] [Reference Citation Analysis]
11 Zaki I, Abu El-Ata SA, Fayad E, Abu Ali OA, Abu Almaaty AH, Saad AS. Evaluation of Synthetic 2,4-Disubstituted-benzo[g]quinoxaline Derivatives as Potential Anticancer Agents. Pharmaceuticals (Basel) 2021;14:853. [PMID: 34577556 DOI: 10.3390/ph14090853] [Reference Citation Analysis]